Literature DB >> 22948546

Concurrent cytomegalovirus and herpes simplex virus infection in pemphigus vulgaris treated with rituximab and prednisolone.

Hsien-Yi Chiu, Chia-Ying Chang, Cheng-Hsiang Hsiao, Li-Fang Wang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22948546     DOI: 10.2340/00015555-1429

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  6 in total

Review 1.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

2.  Is there a causal relationship between HSV-1 and pemphigus vulgaris?

Authors:  María Elisa Vega-Memíje; Francisco Javier García-Vázquez; Juan Carlos Cuevas-González; Erika Rodríguez-Lobato; Marco Antonio Aguilar-Urbano
Journal:  Springerplus       Date:  2015-12-23

3.  Rituximab therapy in a case of pemphigus vulgaris triggering herpes simplex infection at varied sites.

Authors:  Kiran K Chotaliya; Richa Gupta; Yogesh S Marfatia
Journal:  Indian Dermatol Online J       Date:  2015 Nov-Dec

4.  Gastrointestinal cytomegalovirus disease in a patient with pemphigus vulgaris treated with corticosteroid and mycophenolate mofetil.

Authors:  Luiza Barbosa Oliveira; Celina Wakisaka Maruta; Denise Miyamoto; Fernanda Aburesi Salvadori; Claudia Giuli Santi; Valeria Aoki; Amaro Nunes Duarte-Neto
Journal:  Autops Case Rep       Date:  2017-03-30

Review 5.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 6.  Management of Pemphigus in COVID-19 Pandemic Era; a Review Article.

Authors:  Fahimeh Abdollahimajd; Mohammad Shahidi-Dadras; Reza M Robati; Sahar Dadkhahfar
Journal:  Arch Acad Emerg Med       Date:  2020-04-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.